Cancer Research and Treatment

Low-Dose Radiation Reduces Doxorubicin-Induced Myocardial Injury Through Mitochondrial Pathways

Di Zhao, Xin Jiang, Xinxin Meng, Dandan Liu, Yanwei Du, Lijing Zhao, Hongyu Jiang

Dose-Response.2023; 21(1): 155932582311557. CrossRef

Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka

Jayasinghe Arachchige Nirosha Sandamali, Ruwani Punyakanthi Hewawasam, Madappuli Arachchige Chaminda Sri S Fernando, Kamani Ayoma Perera Wijewardana Jayatilaka

Non-coding RNAs, cancer treatment and cardiotoxicity: A triad of new hope

Rishabh Mittal, Sarath Krishnan M P, Rahul Saxena, Ananyan Sampath, Bela Goyal

Cancer Treatment and Research Communications.2023; 36: 100750. CrossRef

Cardiac Biomarkers for the Detection and Management of Cancer Therapy-Related Cardiovascular Toxicity

Xinxin Zhang, Yuxi Sun, Yanli Zhang, Fengqi Fang, Jiwei Liu, Yunlong Xia, Ying Liu

Journal of Cardiovascular Development and Disease.2022; 9(11): 372. CrossRef

Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the “European Paediatric Oncology Off-patents Medicines Consortium” (EPOC) Trial

Farina Hellmann, Swantje Völler, Miriam Krischke, David Jamieson, Nicolas André, Gianni Bisogno, Alan Boddy, Georg Hempel

European Journal of Drug Metabolism and Pharmacokinetics.2020; 45(3): 413. CrossRef

Daniela Cardinale, Fabiani Iacopo, Carlo Maria Cipolla

Frontiers in Cardiovascular Medicine.2020;[Epub] CrossRef

The Role of Biomarkers in Cardio-Oncology

Journal of Cardiovascular Translational Research.2020; 13(3): 431. CrossRef

Cardiotoxicity - the first cause of morbidity and mortality in pediatric patients survivors of acute lymphoblastic leukemia

Letitia Elena Radu, Roxana Corina Sfetea, Constantin Virgiliu Arion, Anca Colita

Revista Romana de Medicina de Laborator.2020; 28(2): 133. CrossRef

Oncologic therapies associated with cardiac toxicities: how to minimize the risks

Daniela Cardinale, Federica Stivala, Carlo M. Cipolla

Expert Review of Anticancer Therapy.2019; 19(5): 359. CrossRef

Biomarkers in cancer therapy related cardiac dysfunction (CTRCD)

Heart Failure Reviews.2018; 23(2): 255. CrossRef

Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress

Faisal Imam, Naif O. Al-Harbi, Mohammed M. Al-Harbia, Hesham M. Korashy, Mushtaq Ahmad Ansari, Mohamed M. Sayed-Ahmed, Mahmoud N. Nagi, Muzaffar Iqbal, Md. Khalid Anwer, Imran Kazmi, Muhammad Afzal, Saleh Bahashwan

Cardiovascular Toxicology.2017; 17(1): 58. CrossRef

Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy

Daniela Cardinale, Gina Biasillo, Michela Salvatici, Maria Teresa Sandri, Carlo Maria Cipolla

Expert Review of Molecular Diagnostics.2017; 17(3): 245. CrossRef

Alternative Biomarkers for Combined Biology

Yong-Hyun Kim, Jennifer Kirsop, Wai Hong Wilson Tang

Heart Failure Clinics.2017; 13(2): 381. CrossRef

Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts

Gina Biasillo, Carlo M. Cipolla, Daniela Cardinale

Current Oncology Reports.2017;[Epub] CrossRef

Cardiovascular Complications of Cancer Therapy

Hui-Ming Chang, Rohit Moudgil, Tiziano Scarabelli, Tochukwu M. Okwuosa, Edward T.H. Yeh

Journal of the American College of Cardiology.2017; 70(20): 2536. CrossRef

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Giuseppe Curigliano, Daniela Cardinale, Susan Dent, Carmen Criscitiello, Olexiy Aseyev, Daniel Lenihan, Carlo Maria Cipolla

CA: A Cancer Journal for Clinicians.2016; 66(4): 309. CrossRef

Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress

Hesham M. Korashy, Ibraheem M. Attafi, Mushtaq A. Ansari, Mohammed A. Assiri, Osamah M. Belali, Sheik F. Ahmad, Ibrahim A. AL-Alallah, Fawaz E.Al Anazi, Abdulqader A. Alhaider

Toxicology Letters.2016; 252: 50. CrossRef

Role of biomarkers in monitoring antiblastic cardiotoxicity

Giuseppina Novo, Christian Cadeddu, Vincenzo Sucato, Pasquale Pagliaro, Silvio Romano, Carlo G. Tocchetti, Concetta Zito, Luca Longobardo, Savina Nodari, Maria Penco

Journal of Cardiovascular Medicine.2016; 17: e27. CrossRef

Biomarkers and Cancer Therapy-Related Cardiac Dysfunction

Prateek Sharma, Mahin Rehman, Javed Butler, Michelle W. Bloom

Current Cardiovascular Risk Reports.2016;[Epub] CrossRef

The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer Therapy

Christine Henri, Therese Heinonen, Jean-Claude Tardif

Biomarkers in Cancer.2016; 8s2: BIC.S31798. CrossRef

Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity

Oncology Letters.2016; 11(5): 3483. CrossRef

Mitogen-Activated Protein Kinases Pathways Mediate the Sunitinib-Induced Hypertrophy in Rat Cardiomyocyte H9c2 Cells

Hesham Mohamed Korashy, Hani A. Al-Suwayeh, Zaid H. Maayah, Mushtaq Ahmad Ansari, Sheikh Fayaz Ahmad, Saleh A. Bakheet

Cardiovascular Toxicology.2015; 15(1): 41. CrossRef

Cardiotoxicity due to Chemotherapy: the Role of Biomarkers

Current Cardiology Reports.2015;[Epub] CrossRef

Cardiac Complications of Chemotherapy: Role of Biomarkers

Alessandro Colombo, Maria T. Sandri, Michela Salvatici, Carlo M. Cipolla, Daniela Cardinale

Current Treatment Options in Cardiovascular Medicine.2014;[Epub] CrossRef

Use of Biomarkers for the Assessment of Chemotherapy-induced Cardiac Toxicity

Eric S. Christenson, Theodore James, Vineet Agrawal, Ben H. Park

Clinical Biochemistry.2014;[Epub] CrossRef

BNP Predicts Chemotherapy-Related Cardiotoxicity and Death: Comparison with Gated Equilibrium Radionuclide Ventriculography

Dorthe Skovgaard, Philip Hasbak, Andreas Kjaer, Claudio Moretti

Using cardiac biomarkers and treating cardiotoxicity in cancer

Future Cardiology.2013; 9(1): 105. CrossRef

Exaggerated NT‐proBNP Production in Patients With Hematologic Malignancies: A Case Series

Congestive Heart Failure.2012; 18(6): 333. CrossRef

Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience

Erkan Dogan, Hikmet Yorgun, Ibrahim Petekkaya, Necla Ozer, Kadri Altundag, Yavuz Ozisik

Medical Oncology.2012; 29(5): 3232. CrossRef

NT-ProBNP and cardiac troponin I in virulent canine babesiosis

Remo Lobetti, Robert Kirberger, Ninette Keller, Frank Kettner, Eran Dvir

Veterinary Parasitology.2012; 190(3-4): 333. CrossRef

Approccio cardiologico al paziente sottoposto a trattamento antitumorale. Documento primo

Lidia Boccardi, Daniela Cardinale, Maurizio Civelli, Chiara Lestuzzi, Carlo Materazzo, Nicola Maurea, Ines Monte, Stefano Oliva, Patrizia Piotti, Giuseppina Quattrocchi, Elisabetta Rossi, Giuseppe Toglia

Journal of Cardiovascular Echography.2011; 21(1): 32. CrossRef

Daniela Cardinale, Michela Salvatici, Maria T. Sandri

Clinical Chemistry and Laboratory Medicine (CCLM).2011;[Epub] CrossRef

Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice

Ahmed M. Al-Abd, Ki-Yun Hong, Soo-Chang Song, Hyo-Jeong Kuh

Journal of Controlled Release.2010; 142(1): 101. CrossRef

Cardiac Involvement in Patients with Hematologic Malignancies

Alessandro Allegra, Andrea Alonci, Sabina Russo, Antonino Cannavò, Giuseppa Penna, Arianna D'Angelo, Giacomo Bellomo, Caterina Musolino

Journal of Investigative Medicine.2010; 58(7): 859. CrossRef